跳至主要内容
临床试验/EUCTR2011-002928-41-AT
EUCTR2011-002928-41-AT进行中(未招募)1 期

Characterization of humoral and cellular immunity for tick-borne encephalitis (TBE) vaccination in allogeneic blood and marrow graft recipients: a pilot study

Med. Uni. Wien, Klinik für Innere I0 个研究点目标入组 52 人开始时间: 2012年11月23日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Adult patients =18 years who
  • -had undergone an allogeneic HSCT 11 to 13 months ago or
  • -healthy volunteers without previous TBE vaccination
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 52
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 0

排除标准

  • -Previous TBE vaccination following HSCT
  • -HSCT patients with extremely severe acute graft versus host disease (receiving prednisone >0.5 mg/kg bodyweight as part of a combination therapy or a three agent immunosuppressive treatment)
  • -Previous TBE virus infection, previous dengue virus infection or vaccination against yellow fever or Japanese encephalitis
  • -Any acute febrile illness in the 2 weeks prior to or at the time of enrolment
  • -A history of severe allergic reactions or anaphylaxis after vaccination
  • -If female, are pregnant or lactating
  • -If belonging to the healthy control group are immunosuppressed

研究者

发起方
Med. Uni. Wien, Klinik für Innere I

相似试验

Characterization of humoral and cellular immunity... | 临床试验